BioWorld MedTech

March 30, 2012

American College of Cardiology 2012: GE Healthcare's Centricity offers data solution for cardiologists

CHICAGO A new IT solution could give cardiologists and clinicians a single point of access to patient data and eliminate the boutique solution that has been the standard of the industry for years now. Read More

Washington roundup: Harkin; contentious add-ons not welcome in user fee bill

Report from Europe: Cardica receives CE mark for MicroCutter Xchange 30 system

Catheter Connections study reveals dirty truth of IV poles

Deals roundup: Roche bumps its Illumina offer price to $51 a share

Financings roundup: EDAP places 5.6M shares; plans 20% debt reduction

Restructuring roundup: Covidien reports organizational changes in Vascular unit

Agreements/contracts: Transparent, MRL to launch new 3-D cell culture system

HIT roundup: LogRhythm integrates SIEM 2.0 with FairWarning solutions

People in the News

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for July 10, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

BioWorld

News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...